101
|
Haberkant P, Stein F, Höglinger D, Gerl MJ, Brügger B, Van Veldhoven PP, Krijgsveld J, Gavin AC, Schultz C. Bifunctional Sphingosine for Cell-Based Analysis of Protein-Sphingolipid Interactions. ACS Chem Biol 2016; 11:222-30. [PMID: 26555438 DOI: 10.1021/acschembio.5b00810] [Citation(s) in RCA: 88] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Sphingolipids are essential structural components of cellular membranes and are crucial regulators of cellular processes. While current high-throughput approaches allow for the systematic mapping of interactions of soluble proteins with their lipid-binding partners, photo-cross-linking is the only technique that enables for the proteome-wide mapping of integral membrane proteins with their direct lipid environment. Here, we report the synthesis of a photoactivatable and clickable analog of sphingosine (pacSph). When administered to sphingosine-1-phosphate lyase deficient cells, pacSph allows its metabolic fate and the subcellular flux of de novo synthesized sphingolipids to be followed in a time-resolved manner. The chemoproteomic profiling yielded over 180 novel sphingolipid-binding proteins, of which we validated a number, demonstrating the unique value of this technique as a discovery tool. This work provides an important resource for the understanding of the global cellular interplay between sphingolipids and their interacting proteins.
Collapse
Affiliation(s)
- Per Haberkant
- European Molecular Biology Laboratory, Cell Biology
and Biophysics Unit, Meyerhofstr.
1, 69117 Heidelberg, Germany
| | - Frank Stein
- European Molecular Biology Laboratory, Cell Biology
and Biophysics Unit, Meyerhofstr.
1, 69117 Heidelberg, Germany
| | - Doris Höglinger
- European Molecular Biology Laboratory, Cell Biology
and Biophysics Unit, Meyerhofstr.
1, 69117 Heidelberg, Germany
| | - Mathias J. Gerl
- Heidelberg University Biochemistry Center, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
| | - Britta Brügger
- Heidelberg University Biochemistry Center, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
| | - Paul P. Van Veldhoven
- Laboratory
for Lipid Biochemistry and Protein Interactions, Department of Cellular
and Molecular Medicine, KU Leuven, B-3000 Leuven, Belgium
| | - Jeroen Krijgsveld
- European Molecular Biology Laboratory, Genome Biology
Unit, Meyerhofstr. 1, 69117 Heidelberg, Germany
| | - Anne-Claude Gavin
- European Molecular Biology Laboratory, Structural
and Computational Biology Unit, Meyerhofstr. 1, 69117 Heidelberg, Germany
| | - Carsten Schultz
- European Molecular Biology Laboratory, Cell Biology
and Biophysics Unit, Meyerhofstr.
1, 69117 Heidelberg, Germany
| |
Collapse
|
102
|
Marques ARA, Mirzaian M, Akiyama H, Wisse P, Ferraz MJ, Gaspar P, Ghauharali-van der Vlugt K, Meijer R, Giraldo P, Alfonso P, Irún P, Dahl M, Karlsson S, Pavlova EV, Cox TM, Scheij S, Verhoek M, Ottenhoff R, van Roomen CPAA, Pannu NS, van Eijk M, Dekker N, Boot RG, Overkleeft HS, Blommaart E, Hirabayashi Y, Aerts JM. Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases. J Lipid Res 2016; 57:451-63. [PMID: 26724485 PMCID: PMC4766994 DOI: 10.1194/jlr.m064923] [Citation(s) in RCA: 50] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2015] [Indexed: 12/20/2022] Open
Abstract
The membrane lipid glucosylceramide (GlcCer) is continuously formed and degraded. Cells express two GlcCer-degrading β-glucosidases, glucocerebrosidase (GBA) and GBA2, located in and outside the lysosome, respectively. Here we demonstrate that through transglucosylation both GBA and GBA2 are able to catalyze in vitro the transfer of glucosyl-moieties from GlcCer to cholesterol, and vice versa. Furthermore, the natural occurrence of 1-O-cholesteryl-β-D-glucopyranoside (GlcChol) in mouse tissues and human plasma is demonstrated using LC-MS/MS and 13C6-labeled GlcChol as internal standard. In cells, the inhibition of GBA increases GlcChol, whereas inhibition of GBA2 decreases glucosylated sterol. Similarly, in GBA2-deficient mice, GlcChol is reduced. Depletion of GlcCer by inhibition of GlcCer synthase decreases GlcChol in cells and likewise in plasma of inhibitor-treated Gaucher disease patients. In tissues of mice with Niemann-Pick type C disease, a condition characterized by intralysosomal accumulation of cholesterol, marked elevations in GlcChol occur as well. When lysosomal accumulation of cholesterol is induced in cultured cells, GlcChol is formed via lysosomal GBA. This illustrates that reversible transglucosylation reactions are highly dependent on local availability of suitable acceptors. In conclusion, mammalian tissues contain GlcChol formed by transglucosylation through β-glucosidases using GlcCer as donor. Our findings reveal a novel metabolic function for GlcCer.
Collapse
Affiliation(s)
- André R A Marques
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | - Mina Mirzaian
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | | | - Patrick Wisse
- Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Maria J Ferraz
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | - Paulo Gaspar
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | | | - Rianne Meijer
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Pilar Giraldo
- Centro de Investigación Biomédica en Red de Enfermedades Raras, Unidad de Investigación Traslacional, Zaragoza, Spain
| | - Pilar Alfonso
- Centro de Investigación Biomédica en Red de Enfermedades Raras, Unidad de Investigación Traslacional, Zaragoza, Spain
| | - Pilar Irún
- Centro de Investigación Biomédica en Red de Enfermedades Raras, Unidad de Investigación Traslacional, Zaragoza, Spain
| | - Maria Dahl
- Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden
| | - Stefan Karlsson
- Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden
| | - Elena V Pavlova
- Addenbrooke's Hospital, Department of Medicine, University of Cambridge, Cambridge, UK
| | - Timothy M Cox
- Addenbrooke's Hospital, Department of Medicine, University of Cambridge, Cambridge, UK
| | - Saskia Scheij
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | - Marri Verhoek
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Roelof Ottenhoff
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | | | - Navraj S Pannu
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Marco van Eijk
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Nick Dekker
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | - Rolf G Boot
- Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Herman S Overkleeft
- Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden, The Netherlands
| | - Edward Blommaart
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | | | - Johannes M Aerts
- Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands Departments of Medical Biochemistry Leiden Institute of Chemistry, Leiden, The Netherlands
| |
Collapse
|
103
|
Navo CD, Corzana F, Sánchez-Fernández EM, Busto JH, Avenoza A, Zurbano MM, Nanba E, Higaki K, Ortiz Mellet C, García Fernández JM, Peregrina JM. Conformationally-locked C-glycosides: tuning aglycone interactions for optimal chaperone behaviour in Gaucher fibroblasts. Org Biomol Chem 2016; 14:1473-84. [DOI: 10.1039/c5ob02281a] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A series of conformationally locked C-glycosides based on the 3-aminopyrano[3,2-b]pyrrol-2(1H)-one (APP) scaffold has been synthesized.
Collapse
Affiliation(s)
- C. D. Navo
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| | - F. Corzana
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| | | | - J. H. Busto
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| | - A. Avenoza
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| | - M. M. Zurbano
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| | - E. Nanba
- Division of Functional Genomics
- Research Center for Bioscience and Technology
- Tottori University
- Yonago 683-8503
- Japan
| | - K. Higaki
- Division of Functional Genomics
- Research Center for Bioscience and Technology
- Tottori University
- Yonago 683-8503
- Japan
| | - C. Ortiz Mellet
- Departamento de Química Orgánica
- Facultad de Química
- Universidad de Sevilla
- 41012 Sevilla
- Spain
| | - J. M. García Fernández
- Instituto de Investigaciones Químicas (IIQ)
- CSIC – Universidad de Sevilla
- 41092 Sevilla
- Spain
| | - J. M. Peregrina
- Departamento de Química and Centro de Investigación en Síntesis Química
- Universidad de La Rioja
- 26006 Logroño
- Spain
| |
Collapse
|
104
|
Chen N, Yu ZH, Zhou D, Hu XL, Zang Y, He XP, Li J, Xie J. N-Oxyamide-linked glycoglycerolipid coated AuNPs for receptor-targeting imaging and drug delivery. Chem Commun (Camb) 2016; 52:2284-7. [DOI: 10.1039/c5cc09749e] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
We report the construction of gold glyconanoparticles coated by N-oxyamide-linked glycoglycerolipids for receptor-targeting imaging and drug delivery.
Collapse
Affiliation(s)
- Na Chen
- PPSM
- ENS Cachan
- CNRS
- Université Paris-Saclay
- Cachan
| | - Zhi-Hao Yu
- Key Laboratory for Advanced Materials & Institute of Fine Chemicals
- East China University of Science and Technology
- Shanghai 200237
- PR China
| | - Dan Zhou
- Key Laboratory for Advanced Materials & Institute of Fine Chemicals
- East China University of Science and Technology
- Shanghai 200237
- PR China
| | - Xi-Le Hu
- Key Laboratory for Advanced Materials & Institute of Fine Chemicals
- East China University of Science and Technology
- Shanghai 200237
- PR China
| | - Yi Zang
- National Center for Drug Screening
- State Key Laboratory of Drug Research
- Shanghai Institute of Materia Medica (SIMM)
- Chinese Academy of Sciences (CAS)
- Shanghai 201203
| | - Xiao-Peng He
- Key Laboratory for Advanced Materials & Institute of Fine Chemicals
- East China University of Science and Technology
- Shanghai 200237
- PR China
| | - Jia Li
- National Center for Drug Screening
- State Key Laboratory of Drug Research
- Shanghai Institute of Materia Medica (SIMM)
- Chinese Academy of Sciences (CAS)
- Shanghai 201203
| | - Juan Xie
- PPSM
- ENS Cachan
- CNRS
- Université Paris-Saclay
- Cachan
| |
Collapse
|
105
|
5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease. Carbohydr Res 2015; 420:6-12. [PMID: 26717544 DOI: 10.1016/j.carres.2015.10.009] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2015] [Revised: 10/13/2015] [Accepted: 10/23/2015] [Indexed: 11/20/2022]
Abstract
Electrophilic fluorination of an exocyclic methoxymethylene enol ether derived from N-tert-butyloxycarbonyl-1,5-dideoxy-1,5-imino-3,4-O-isopropylidene-D-erythro-pent-2-ulose (11) provided the 5-fluoro derivative of the powerful β-galactosidase inhibitor 4-epi-isofagomine (8). This structural alteration, in combination with N-alkylation, led to considerably improved α-galactosidase selectivity. New compounds may serve as leads en route to new pharmacological chaperones for Fabry's disease.
Collapse
|
106
|
Stanková K, Martinková M, Gonda J, Bago M, Pilátová M, Gönciová G. The convergent total synthesis of cytotoxic homospisulosine and its 3-epi-analogue. ACTA ACUST UNITED AC 2015. [DOI: 10.1016/j.tetasy.2015.11.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
107
|
Sugimoto M, Shimizu Y, Yoshioka T, Wakabayashi M, Tanaka Y, Higashino K, Numata Y, Sakai S, Kihara A, Igarashi Y, Kuge Y. Histological analyses by matrix-assisted laser desorption/ionization-imaging mass spectrometry reveal differential localization of sphingomyelin molecular species regulated by particular ceramide synthase in mouse brains. Biochim Biophys Acta Mol Cell Biol Lipids 2015; 1851:1554-65. [DOI: 10.1016/j.bbalip.2015.09.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2015] [Revised: 08/18/2015] [Accepted: 09/16/2015] [Indexed: 11/27/2022]
|
108
|
del Solar V, Lizardo D, Li N, Hurst J, Brais C, Atilla-Gokcumen G. Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis. ACTA ACUST UNITED AC 2015; 22:1662-70. [DOI: 10.1016/j.chembiol.2015.11.004] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2015] [Revised: 11/02/2015] [Accepted: 11/06/2015] [Indexed: 01/06/2023]
|
109
|
van den Berg RJBHN, van Rijssel ER, Ferraz MJ, Houben J, Strijland A, Donker-Koopman WE, Wennekes T, Bonger KM, Ghisaidoobe ABT, Hoogendoorn S, van der Marel GA, Codée JDC, Overkleeft HS, Aerts JMFG. Synthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors. ChemMedChem 2015; 10:2042-62. [DOI: 10.1002/cmdc.201500407] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Indexed: 01/08/2023]
Affiliation(s)
| | - Erwin R. van Rijssel
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Maria Joao Ferraz
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Judith Houben
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Anneke Strijland
- Department of Medical Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 9 1105 AZ Amsterdam The Netherlands
| | - Wilma E. Donker-Koopman
- Department of Medical Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 9 1105 AZ Amsterdam The Netherlands
| | - Tom Wennekes
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
- Laboratory of Organic Chemistry; Wageningen University; Dreijenplein 8 6703 HB Wageningen The Netherlands
| | - Kimberly M. Bonger
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Amar B. T. Ghisaidoobe
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Sascha Hoogendoorn
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Gijsbert A. van der Marel
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Jeroen D. C. Codée
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Herman S. Overkleeft
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
| | - Johannes M. F. G. Aerts
- Leiden Institute of Chemistry; Leiden University; Gorlaeus Laboratories; Einsteinweg 55 2300 RA Leiden The Netherlands
- Department of Medical Biochemistry; Academic Medical Center; University of Amsterdam; Meibergdreef 9 1105 AZ Amsterdam The Netherlands
| |
Collapse
|
110
|
Goto K, Suzuki T, Tamai H, Ogawa J, Imamura A, Ando H, Ishida H, Kiso M. Total Synthesis and Neuritogenic Activity Evaluation of Ganglioside PNG-2A from the StarfishProtoreaster nodosus. ASIAN J ORG CHEM 2015. [DOI: 10.1002/ajoc.201500282] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Kenta Goto
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
| | - Tatsuya Suzuki
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
- Institute for Integrated Cell-Material Sciences (WPI-iCeMS); Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku; Kyoto 606-8501 Japan
| | - Hideki Tamai
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
- Institute for Integrated Cell-Material Sciences (WPI-iCeMS); Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku; Kyoto 606-8501 Japan
| | - Junya Ogawa
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
| | - Akihiro Imamura
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
| | - Hiromune Ando
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
- Institute for Integrated Cell-Material Sciences (WPI-iCeMS); Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku; Kyoto 606-8501 Japan
| | - Hideharu Ishida
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
| | - Makoto Kiso
- Department of Applied Bioorganic Chemistry; Gifu University; 1-1 Yanagido, Gifu-shi Gifu 501-1193 Japan
- Institute for Integrated Cell-Material Sciences (WPI-iCeMS); Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku; Kyoto 606-8501 Japan
| |
Collapse
|
111
|
Mena-Barragán T, Narita A, Matias D, Tiscornia G, Nanba E, Ohno K, Suzuki Y, Higaki K, Garcia Fernández JM, Ortiz Mellet C. pH-Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases. Angew Chem Int Ed Engl 2015; 54:11696-700. [PMID: 26386364 DOI: 10.1002/anie.201505147] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2015] [Indexed: 11/06/2022]
Abstract
A general approach is reported for the design of small-molecule competitive inhibitors of lysosomal glycosidases programmed to 1) promote correct folding of mutant enzymes at the endoplasmic reticulum, 2) facilitate trafficking, and 3) undergo dissociation and self-inactivation at the lysosome. The strategy is based on the incorporation of an orthoester segment into iminosugar conjugates to switch the nature of the aglycone moiety from hydrophobic to hydrophilic in the pH 7 to pH 5 window, which has a dramatic effect on the enzyme binding affinity. As a proof of concept, new highly pH-responsive glycomimetics targeting human glucocerebrosidase or α-galactosidase with strong potential as pharmacological chaperones for Gaucher or Fabry disease, respectively, were developed.
Collapse
Affiliation(s)
- Teresa Mena-Barragán
- Department of Organic Chemistry, Faculty of Chemistry, University of Sevilla c/Profesor García González 1, 41011 Sevilla (Spain)
| | - Aya Narita
- Division of Child Neurology, Tottori University Faculty of Medicine, Yonago 683-8504 (Japan)
| | - Dino Matias
- Center for Biomedical Research, Depertamento de Ciencias, Biomedicas y Medicina/Programa de Medicina Regenerativa, Universidad do Algarve (Portugal)
| | - Gustavo Tiscornia
- Center for Biomedical Research, Depertamento de Ciencias, Biomedicas y Medicina/Programa de Medicina Regenerativa, Universidad do Algarve (Portugal)
| | - Eiji Nanba
- Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University, 86 Nishi-cho, Yonago 683-8503 (Japan)
| | | | - Yoshiyuki Suzuki
- Tokyo Metropolitan Institute of Medical Science, Tokyo 204-8588 (Japan)
| | - Katsumi Higaki
- Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University, 86 Nishi-cho, Yonago 683-8503 (Japan).
| | - José Manuel Garcia Fernández
- Instituto de Investigaciones Químicas (IIQ), CSIC-Universidad de Sevilla, Américo Vespucio 49, 41092 Sevilla (Spain).
| | - Carmen Ortiz Mellet
- Department of Organic Chemistry, Faculty of Chemistry, University of Sevilla c/Profesor García González 1, 41011 Sevilla (Spain).
| |
Collapse
|
112
|
Mena-Barragán T, Narita A, Matias D, Tiscornia G, Nanba E, Ohno K, Suzuki Y, Higaki K, Garcia Fernández JM, Ortiz Mellet C. pH-Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201505147] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
113
|
Canela N, Herrero P, Mariné S, Nadal P, Ras MR, Rodríguez MÁ, Arola L. Analytical methods in sphingolipidomics: Quantitative and profiling approaches in food analysis. J Chromatogr A 2015; 1428:16-38. [PMID: 26275862 DOI: 10.1016/j.chroma.2015.07.110] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2015] [Revised: 07/27/2015] [Accepted: 07/31/2015] [Indexed: 02/07/2023]
Abstract
In recent years, sphingolipidomics has emerged as an interesting omic science that encompasses the study of the full sphingolipidome characterization, content, structure and activity in cells, tissues or organisms. Like other omics, it has the potential to impact biomarker discovery, drug development and systems biology knowledge. Concretely, dietary food sphingolipids have gained considerable importance due to their extensively reported bioactivity. Because of the complexity of this lipid family and their diversity among foods, powerful analytical methodologies are needed for their study. The analytical tools developed in the past have been improved with the enormous advances made in recent years in mass spectrometry (MS) and chromatography, which allow the convenient and sensitive identification and quantitation of sphingolipid classes and form the basis of current sphingolipidomics methodologies. In addition, novel hyphenated nuclear magnetic resonance (NMR) strategies, new ionization strategies, and MS imaging are outlined as promising technologies to shape the future of sphingolipid analyses. This review traces the analytical methods of sphingolipidomics in food analysis concerning sample extraction, chromatographic separation, the identification and quantification of sphingolipids by MS and their structural elucidation by NMR.
Collapse
Affiliation(s)
- Núria Canela
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain
| | - Pol Herrero
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain
| | - Sílvia Mariné
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain
| | - Pedro Nadal
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain
| | - Maria Rosa Ras
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain
| | | | - Lluís Arola
- Centre for Omic Sciences, Universitat Rovira i Virgili (COS-URV), Spain.
| |
Collapse
|
114
|
Kallemeijn WW, Witte MD, Wennekes T, Aerts JMFG. Mechanism-based inhibitors of glycosidases: design and applications. Adv Carbohydr Chem Biochem 2015; 71:297-338. [PMID: 25480507 DOI: 10.1016/b978-0-12-800128-8.00004-2] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
This article covers recent developments in the design and application of activity-based probes (ABPs) for glycosidases, with emphasis on the different enzymes involved in metabolism of glucosylceramide in humans. Described are the various catalytic reaction mechanisms employed by inverting and retaining glycosidases. An understanding of catalysis at the molecular level has stimulated the design of different types of ABPs for glycosidases. Such compounds range from (1) transition-state mimics tagged with reactive moieties, which associate with the target active site—forming covalent bonds in a relatively nonspecific manner in or near the catalytic pocket—to (2) enzyme substrates that exploit the catalytic mechanism of retaining glycosidase targets to release a highly reactive species within the active site of the enzyme, to (3) probes based on mechanism-based, covalent, and irreversible glycosidase inhibitors. Some applications in biochemical and biological research of the activity-based glycosidase probes are discussed, including specific quantitative visualization of active enzyme molecules in vitro and in vivo, and as strategies for unambiguously identifying catalytic residues in glycosidases in vitro.
Collapse
Affiliation(s)
- Wouter W Kallemeijn
- Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
| | - Martin D Witte
- Department of Bio-Organic Chemistry, Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands.
| | - Tom Wennekes
- Department of Synthetic Organic Chemistry, Wageningen University, Wageningen, The Netherlands.
| | - Johannes M F G Aerts
- Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
| |
Collapse
|
115
|
Sanllehí P, Abad JL, Casas J, Delgado A. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase). Chem Phys Lipids 2015. [PMID: 26200919 DOI: 10.1016/j.chemphyslip.2015.07.007] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Sphingolipids (SLs) are essential structural and signaling molecules of eukaryotic cells. Among them, sphingosine 1 phosphate (S1P) is a recognized promoter of cell survival, also involved, inter alia, in inflammation and tumorigenesis processes. The knowledge and modulation of the enzymes implicated in the biosynthesis and degradation of S1P are capital to control the intracellular levels of this lipid and, ultimately, to determine the cell fate. Starting with a general overview of the main metabolic pathways involved in SL metabolism, this review is mainly focused on the description of the most relevant findings concerning the development of modulators of S1P, namely inhibitors of the enzymes regulating S1P synthesis (sphingosine kinases) and degradation (sphingosine 1 phosphate phosphatase and lyase). In addition, a brief overview of the most significant agonists and antagonists at the S1P receptors is also addressed.
Collapse
Affiliation(s)
- Pol Sanllehí
- Research Unit on Bioactive Molecules, Department of Biomedicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, E-08034 Barcelona, Spain; University of Barcelona (UB), Faculty of Pharmacy, Department of Pharmacology and Medicinal Chemistry, Unit of Pharmaceutical Chemistry (Associated Unit to CSIC), Avga. Joan XXIII s/n, E-08028 Barcelona, Spain
| | - José-Luis Abad
- Research Unit on Bioactive Molecules, Department of Biomedicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, E-08034 Barcelona, Spain
| | - Josefina Casas
- Research Unit on Bioactive Molecules, Department of Biomedicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, E-08034 Barcelona, Spain
| | - Antonio Delgado
- Research Unit on Bioactive Molecules, Department of Biomedicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, E-08034 Barcelona, Spain; University of Barcelona (UB), Faculty of Pharmacy, Department of Pharmacology and Medicinal Chemistry, Unit of Pharmaceutical Chemistry (Associated Unit to CSIC), Avga. Joan XXIII s/n, E-08028 Barcelona, Spain.
| |
Collapse
|
116
|
Hoogendoorn S, Mock ED, Strijland A, Donker-Koopman WE, van den Elst H, van den Berg RJBHN, Aerts JMFG, van der Marel GA, Overkleeft HS. ortho-Carborane-ModifiedN-Substituted Deoxynojirimycins. European J Org Chem 2015. [DOI: 10.1002/ejoc.201500364] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
117
|
Subathra M, Korrapati M, Howell LA, Arthur JM, Shayman JA, Schnellmann RG, Siskind LJ. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Am J Physiol Renal Physiol 2015; 309:F204-15. [PMID: 26041445 DOI: 10.1152/ajprenal.00150.2015] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Accepted: 05/27/2015] [Indexed: 12/11/2022] Open
Abstract
Glycosphingolipids (GSLs) play a role in insulin resistance and diabetes, but their role in diabetic nephropathy (DN) has received limited attention. We used 9- and 17-wk-old nondiabetic db/m and diabetic db/db mice to examine the role of GSLs in DN. Cerebrosides or monoglycosylated GSLs [hexosylceramides (HexCers); glucosyl- and galactosylceramides] and lactosylceramide (LacCers) were elevated in db/db mouse kidney cortices, specifically in glomeruli, and also in urine. In our recent paper (25), we observed that the kidneys exhibited glomerular hypertrophy and proximal tubular vacuolization and increased fibrosis markers at these time points. Mesangial cells contribute to hyperglycemia-induced glomerular hypertrophy in DN. Hyperglycemic culture conditions, similar to that present in diabetes, were sufficient to elevate mesangial cell HexCers and increase markers of fibrosis, extracellular matrix proteins, and cellular hypertrophy. Inhibition of glucosylceramide synthase or lowering glucose levels decreased markers of fibrosis and extracellular matrix proteins and reversed mesangial cell hypertrophy. Hyperglycemia increased phosphorylated (p)SMAD3 and pAkt levels and reduced phosphatase and tensin homolog levels, which were reversed with glucosylceramide synthase inhibition. These data suggest that inhibition of glucosylceramide synthase reversed mesangial cell hypertrophy through decreased pAkt and pSmad3 and increased pathways responsible for protein degradation. Importantly, urinary GSL levels were higher in patients with DN compared with healthy control subjects, implicating a role for these lipids in human DN. Thus, hyperglycemia in type II diabetes leads to renal dysfunction at least in part by inducing accumulation of HexCers and LacCers in mesangial cells, resulting in fibrosis, extracellular matrix production, and hypertrophy.
Collapse
Affiliation(s)
- Marimuthu Subathra
- Department of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky
| | - Midhun Korrapati
- Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina
| | - Lauren A Howell
- Department of Biomedical Sciences, Florida State University, Tallahassee, Florida
| | - John M Arthur
- University of Arkansas for Medical Sciences, Little Rock, Arkansas; Central Arkansas Veterans Healthcare System, Little Rock, Arkansas
| | - James A Shayman
- Nephrology Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; and
| | - Rick G Schnellmann
- Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina
| | - Leah J Siskind
- Department of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky;
| |
Collapse
|
118
|
Wisse P, Gold H, Mirzaian M, Ferraz MJ, Lutteke G, van den Berg RJBHN, van den Elst H, Lugtenburg J, van der Marel GA, Aerts JMFG, Codée JDC, Overkleeft HS. Synthesis of a Panel of Carbon-13-Labelled (Glyco)Sphingolipids. European J Org Chem 2015. [DOI: 10.1002/ejoc.201500025] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
119
|
Comprehensive characterization of sphingolipid ceramide N-deacylase for the synthesis and fatty acid remodeling of glycosphingolipids. Appl Microbiol Biotechnol 2015; 99:6715-26. [DOI: 10.1007/s00253-015-6421-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Revised: 01/14/2015] [Accepted: 01/19/2015] [Indexed: 10/24/2022]
|
120
|
Seo CH, Kim JB. Therapeutic Potential of Resveratrol in Type I Gaucher Disease. Phytother Res 2015; 29:835-9. [PMID: 25644594 DOI: 10.1002/ptr.5304] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2014] [Revised: 12/10/2014] [Accepted: 01/03/2015] [Indexed: 11/08/2022]
Abstract
Resveratrol is a natural polyphenol that possesses various beneficial properties, such as anti-inflammatory, anti-oxidant, and neuroprotective effects. This study evaluated the potential therapeutic effects of resveratrol on primary fibroblasts derived from a patient with Gaucher disease. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were carried out to determine whether resveratrol affects cell survival. Changes in the expression levels of apoptosis-inducing factor (AIF), Bax, cleaved caspase-3, acetyl-coenzyme A acetyltransferase 1 (ACAT1), E3-binding protein (E3BP), and citrate synthase (CS) were determined by western immunoblot to characterize the effect of resveratrol treatment on Gaucher disease cells. Intracellular glucosylceramide levels in resveratrol-treated patient cells were determined by thin-layer chromatography (TLC). Resveratrol significantly increased the viability of patient cells in comparison with that of control cells. After exposure to resveratrol, expression levels of the apoptotic factors AIF, Bax, and cleaved caspase-3 dose-dependently decreased, while those of ACAT1, E3BP, and CS dose-dependently increased. TLC showed a significant decrease in glucosylceramide levels in patient cells treated with resveratrol. These findings demonstrate that resveratrol can reduce apoptotic events and glucosylceramide levels in Gaucher disease cells, and that it merits further research as a possible therapeutic compound.
Collapse
Affiliation(s)
- Cheong Hoon Seo
- Department of Rehabilitation Medicine, Hallym University Hangang Sacred Heart Hospital, Seoul, Republic of Korea
| | - June-Bum Kim
- Department of Pediatrics, Hallym University Hangang Sacred Heart Hospital, Seoul, Republic of Korea
| |
Collapse
|
121
|
Thiery E, Reniers J, Wouters J, Vincent SP. Stereoselective Synthesis of Boat-Locked Glycosides Designed as Glycosyl Hydrolase Conformational Probes. European J Org Chem 2015. [DOI: 10.1002/ejoc.201403363] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
122
|
Zhu T, Xu L, Xu X, Wang Z, Zhu J, Xie Q, Zhang B, Wang Y, Ju L, He Y, Ye X, Zhou D, Li Y. Analysis of breast cancer-associated glycosphingolipids using electrospray ionization-linear ion trap quadrupole mass spectrometry. Carbohydr Res 2015; 402:189-99. [DOI: 10.1016/j.carres.2014.10.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Revised: 09/27/2014] [Accepted: 10/14/2014] [Indexed: 10/24/2022]
|
123
|
Yoo S, Kim JB. Anti-apoptotic and Beneficial Metabolic Activities of Resveratrol in Type II Gaucher Disease. Biol Pharm Bull 2015; 38:913-8. [DOI: 10.1248/bpb.b14-00712] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Soojin Yoo
- Department of Health and Kinesiology, The University of Texas-Pan American
| | - June-Bum Kim
- Department of Pediatrics, Hallym University College of Medicine
| |
Collapse
|
124
|
Total synthesis of pachastrissamine together with its 4-epi-congener via [3,3]-sigmatropic rearrangements and antiproliferative/cytotoxic evaluation. Carbohydr Res 2015; 402:6-24. [DOI: 10.1016/j.carres.2014.11.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Revised: 11/10/2014] [Accepted: 11/17/2014] [Indexed: 11/24/2022]
|
125
|
Decroocq C, Stauffert F, Pamlard O, Oulaïdi F, Gallienne E, Martin OR, Guillou C, Compain P. Iminosugars as a new class of cholinesterase inhibitors. Bioorg Med Chem Lett 2014; 25:830-3. [PMID: 25597004 DOI: 10.1016/j.bmcl.2014.12.071] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Revised: 12/18/2014] [Accepted: 12/19/2014] [Indexed: 12/21/2022]
Abstract
To further extend the scope of iminosugar biological activity, a systematic structure-activity relationship investigation has been performed by synthesizing and evaluating as cholinesterase inhibitors a library of twenty-three iminoalditols with different substitutions and stereochemistry patterns. These compounds have been evaluated in vitro for the inhibition of cholinesterases (different sources of acetylcholinesterase and butyrylcholinesterase). Some compounds have IC50 values in the micromolar range and display significant inhibition selectivity for butyrylcholinesterase over acetylcholinesterase. These are the first examples of iminosugar-based inhibitors of cholinesterases.
Collapse
Affiliation(s)
- Camille Decroocq
- Laboratoire de Synthèse Organique et Molécules Bioactives, Université de Strasbourg/CNRS (UMR 7509), Ecole Européenne de Chimie, Polymères et Matériaux, 25 rue Becquerel, 67087 Strasbourg, France
| | - Fabien Stauffert
- Laboratoire de Synthèse Organique et Molécules Bioactives, Université de Strasbourg/CNRS (UMR 7509), Ecole Européenne de Chimie, Polymères et Matériaux, 25 rue Becquerel, 67087 Strasbourg, France
| | - Olivier Pamlard
- ICSN-CNRS (Bat. 27)-LabEx LERMIT, 1, Avenue de la Terrasse, 91198 Gif-sur-Yvette Cedex, France
| | - Farah Oulaïdi
- ICOA, UMR 7311, Université d'Orléans et CNRS, rue de Chartres, BP 6759, 45067 Orléans, France
| | - Estelle Gallienne
- ICOA, UMR 7311, Université d'Orléans et CNRS, rue de Chartres, BP 6759, 45067 Orléans, France
| | - Olivier R Martin
- ICOA, UMR 7311, Université d'Orléans et CNRS, rue de Chartres, BP 6759, 45067 Orléans, France
| | - Catherine Guillou
- ICSN-CNRS (Bat. 27)-LabEx LERMIT, 1, Avenue de la Terrasse, 91198 Gif-sur-Yvette Cedex, France.
| | - Philippe Compain
- Laboratoire de Synthèse Organique et Molécules Bioactives, Université de Strasbourg/CNRS (UMR 7509), Ecole Européenne de Chimie, Polymères et Matériaux, 25 rue Becquerel, 67087 Strasbourg, France; Institut Universitaire de France, 103 Bd Saint-Michel, 75005 Paris, France.
| |
Collapse
|
126
|
Abstract
The biological relevance of sialic acid-containing glycans (sialo-glycans) to various interactions at the cell surface has increased the demand for the supply of structurally defined sialo-glycans. Due to their unique structures, the stereoselective synthesis of glycosides of sialic acid is inherently difficult, which makes the synthetic approach to synthesize diverse and complex sialo-glycans far from successful. However, the gap between the chemical and natural synthesis of complex sialo-glycans is narrowing through the emergence of synthetic methods. This review highlights recent progress made in the synthesis of complex sialo-glycans via cutting-edge synthetic methods.
Collapse
Affiliation(s)
- Hiromune Ando
- a Department of Applied Bioorganic Chemistry , Gifu University , Gifu , Japan
| |
Collapse
|
127
|
Sánchez-Fernández EM, Álvarez E, Ortiz Mellet C, García Fernández JM. Synthesis of Multibranched Australine Derivatives from Reducing Castanospermine Analogues through the Amadori Rearrangement of gem-Diamine Intermediates: Selective Inhibitors of β-Glucosidase. J Org Chem 2014; 79:11722-8. [DOI: 10.1021/jo5025283] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Elena M. Sánchez-Fernández
- Departamento
de Química Orgánica, Facultad de Química, Universidad de Sevilla, c/Profesor García González 1, E-41012 Sevilla, Spain
| | - Eleuterio Álvarez
- Instituto
de Investigaciones Químicas, CSIC − Universidad de Sevilla, c/Américo Vespucio 49, Isla de la Cartuja, E-41092 Sevilla, Spain
| | - Carmen Ortiz Mellet
- Departamento
de Química Orgánica, Facultad de Química, Universidad de Sevilla, c/Profesor García González 1, E-41012 Sevilla, Spain
| | - José M. García Fernández
- Instituto
de Investigaciones Químicas, CSIC − Universidad de Sevilla, c/Américo Vespucio 49, Isla de la Cartuja, E-41092 Sevilla, Spain
| |
Collapse
|
128
|
Ghisaidoobe AT, van den Berg RJBHN, Butt SS, Strijland A, Donker-Koopman WE, Scheij S, van den Nieuwendijk AMCH, Koomen GJ, van Loevezijn A, Leemhuis M, Wennekes T, van der Stelt M, van der Marel GA, van Boeckel CAA, Aerts JMFG, Overkleeft HS. Identification and Development of Biphenyl Substituted Iminosugars as Improved Dual Glucosylceramide Synthase/Neutral Glucosylceramidase Inhibitors. J Med Chem 2014; 57:9096-104. [DOI: 10.1021/jm501181z] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Amar T. Ghisaidoobe
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| | | | - Saleem S. Butt
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| | - Anneke Strijland
- Department of Medical Biochemistry,
Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
| | - Wilma E. Donker-Koopman
- Department of Medical Biochemistry,
Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
| | - Saskia Scheij
- Department of Medical Biochemistry,
Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
| | | | - Gerrit-Jan Koomen
- van
‘t Hoff Institute for Molecular Sciences, University of Amsterdam, , P.O. Box
94157, 1090 GD Amsterdam, The Netherlands
| | - Arnold van Loevezijn
- van
‘t Hoff Institute for Molecular Sciences, University of Amsterdam, , P.O. Box
94157, 1090 GD Amsterdam, The Netherlands
| | - Mark Leemhuis
- van
‘t Hoff Institute for Molecular Sciences, University of Amsterdam, , P.O. Box
94157, 1090 GD Amsterdam, The Netherlands
| | - Tom Wennekes
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| | - Mario van der Stelt
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| | - Gijsbert A. van der Marel
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| | - Constant A. A. van Boeckel
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
- Pivot Park Screening
Centre, Molenstraat 110, 5342 CC Oss, The Netherlands
| | - Johannes M. F. G. Aerts
- Department of Medical Biochemistry,
Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
| | - Herman S. Overkleeft
- Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, Einsteinweg
55, 2300 RA Leiden, The Netherlands
| |
Collapse
|
129
|
Kain L, Webb B, Anderson BL, Deng S, Holt M, Costanzo A, Constanzo A, Zhao M, Self K, Teyton A, Everett C, Kronenberg M, Zajonc DM, Bendelac A, Savage PB, Teyton L. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. Immunity 2014; 41:543-54. [PMID: 25367571 PMCID: PMC4220304 DOI: 10.1016/j.immuni.2014.08.017] [Citation(s) in RCA: 165] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2014] [Accepted: 08/11/2014] [Indexed: 11/28/2022]
Abstract
Glycosylceramides in mammalian species are thought to be present in the form of β-anomers. This conclusion was reinforced by the identification of only one glucosylceramide and one galactosylceramide synthase, both β-transferases, in mammalian genomes. Thus, the possibility that small amounts of α-anomers could be produced by an alternative enzymatic pathway, by an unfaithful enzyme, or spontaneously in unusual cellular compartments has not been examined in detail. We approached the question by taking advantage of the exquisite specificity of T and B lymphocytes and combined it with the specificity of catabolic enzymes of the sphingolipid pathway. Here, we demonstrate that mammalian immune cells produce constitutively very small quantities of α-glycosylceramides, which are the major endogenous ligands of natural killer T cells. Catabolic enzymes of the ceramide and glycolipid pathway tightly control the amount of these α-glycosylceramides. The exploitation of this pathway to manipulate the immune response will create new therapeutic opportunities.
Collapse
Affiliation(s)
- Lisa Kain
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | - Bill Webb
- Department of Molecular Biology, the Scripps Research Institute, La Jolla, CA 92037, USA
| | - Brian L Anderson
- Department of Chemistry, Brigham Young University, Provo, UT 84602, USA
| | - Shenglou Deng
- Department of Chemistry, Brigham Young University, Provo, UT 84602, USA
| | - Marie Holt
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | | | - Anne Constanzo
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | - Meng Zhao
- La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037, USA
| | - Kevin Self
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | - Anais Teyton
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | - Chris Everett
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA
| | | | - Dirk M Zajonc
- La Jolla Institute for Allergy & Immunology, La Jolla, CA 92037, USA
| | - Albert Bendelac
- Committee on Immunology, University of Chicago, Chicago, IL 60637, USA
| | - Paul B Savage
- Department of Chemistry, Brigham Young University, Provo, UT 84602, USA
| | - Luc Teyton
- Department of Immunology and Microbial Science, the Scripps Research Institute, La Jolla, CA 92037, USA.
| |
Collapse
|
130
|
Tabor RF, Tan DD, Han SS, Young SA, Seeger ZLE, Pottage MJ, Garvey CJ, Wilkinson BL. Reversible pH‐ and Photocontrollable Carbohydrate‐Based Surfactants. Chemistry 2014; 20:13881-4. [DOI: 10.1002/chem.201404945] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2014] [Indexed: 12/17/2022]
Affiliation(s)
- Rico F. Tabor
- School of Chemistry, Monash University, Victoria 3800 (Australia)
| | - David D. Tan
- School of Chemical and Life Sciences, Nanyang Polytechnic, Singapore 569830 (Singapore)
| | - Sean S. Han
- School of Chemical and Life Sciences, Nanyang Polytechnic, Singapore 569830 (Singapore)
| | - Scott A. Young
- School of Chemistry, Monash University, Victoria 3800 (Australia)
| | - Zoe L. E. Seeger
- School of Chemistry, Monash University, Victoria 3800 (Australia)
| | | | | | | |
Collapse
|
131
|
Willems LI, Jiang J, Li KY, Witte MD, Kallemeijn WW, Beenakker TJN, Schröder SP, Aerts JMFG, van der Marel GA, Codée JDC, Overkleeft HS. From Covalent Glycosidase Inhibitors to Activity-Based Glycosidase Probes. Chemistry 2014; 20:10864-72. [DOI: 10.1002/chem.201404014] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
132
|
Ferraz MJ, Kallemeijn WW, Mirzaian M, Herrera Moro D, Marques A, Wisse P, Boot RG, Willems LI, Overkleeft H, Aerts J. Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses. Biochim Biophys Acta Mol Cell Biol Lipids 2014; 1841:811-25. [DOI: 10.1016/j.bbalip.2013.11.004] [Citation(s) in RCA: 71] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2013] [Revised: 10/25/2013] [Accepted: 11/05/2013] [Indexed: 10/26/2022]
|
133
|
Collins PM, Bum-Erdene K, Yu X, Blanchard H. Galectin-3 Interactions with Glycosphingolipids. J Mol Biol 2014; 426:1439-51. [DOI: 10.1016/j.jmb.2013.12.004] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2013] [Revised: 11/29/2013] [Accepted: 12/02/2013] [Indexed: 11/24/2022]
|
134
|
Alcaide A, Llebaria A. Aziridine Ring Opening for the Synthesis of Sphingolipid Analogues: Inhibitors of Sphingolipid-Metabolizing Enzymes. J Org Chem 2014; 79:2993-3029. [DOI: 10.1021/jo500061w] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Anna Alcaide
- Medicinal Chemistry Laboratory (MedChemLab), Departament
de Química Biomèdica, Institut de Química Avançada de Catalunya (IQAC−CSIC), Jordi Girona 18-26, Barcelona 08034, Spain
| | - Amadeu Llebaria
- Medicinal Chemistry Laboratory (MedChemLab), Departament
de Química Biomèdica, Institut de Química Avançada de Catalunya (IQAC−CSIC), Jordi Girona 18-26, Barcelona 08034, Spain
| |
Collapse
|
135
|
Patzel KA, Yardeni T, Poëc-Celic EL, Leoyklang P, Dorward H, Alonzi DS, Kukushkin NV, Xu B, Zhang Y, Sollogoub M, Blériot Y, Gahl WA, Huizing M, Butters TD. Non-specific accumulation of glycosphingolipids in GNE myopathy. J Inherit Metab Dis 2014; 37:297-308. [PMID: 24136589 PMCID: PMC3979983 DOI: 10.1007/s10545-013-9655-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 07/30/2013] [Accepted: 09/11/2013] [Indexed: 01/06/2023]
Abstract
BACKGROUND UDP-GlcNAc 2-epimerase/ManNAc 6-kinase (GNE) is a bifunctional enzyme responsible for the first committed steps in the synthesis of sialic acid, a common terminal monosaccharide in both protein and lipid glycosylation. GNE mutations are responsible for a rare autosomal recessive neuromuscular disorder, GNE myopathy (also called hereditary inclusion body myopathy). The connection between the impairment of sialic acid synthesis and muscle pathology in GNE myopathy remains poorly understood. METHODS Glycosphingolipid (GSL) analysis was performed by HPLC in multiple models of GNE myopathy, including patients' fibroblasts and plasma, control fibroblasts with inhibited GNE epimerase activity through a novel imino sugar, and tissues of Gne(M712T/M712T) knock-in mice. RESULTS Not only neutral GSLs, but also sialylated GSLs, were significantly increased compared to controls in all tested models of GNE myopathy. Treatment of GNE myopathy fibroblasts with N-acetylmannosamine (ManNAc), a sialic acid precursor downstream of GNE epimerase activity, ameliorated the increased total GSL concentrations. CONCLUSION GNE myopathy models have increased total GSL concentrations. ManNAc supplementation results in decrease of GSL levels, linking abnormal increase of total GSLs in GNE myopathy to defects in the sialic acid biosynthetic pathway. These data advocate for further exploring GSL concentrations as an informative biomarker, not only for GNE myopathy, but also for other disorders of sialic acid metabolism.
Collapse
Affiliation(s)
- Katherine A. Patzel
- Oxford Glycobiology Institute, Department of Biochemistry,
University of Oxford, Oxford, OX1 3QU, United Kingdom
- Medical Genetics Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda MD, 20892, USA
| | - Tal Yardeni
- Oxford Glycobiology Institute, Department of Biochemistry,
University of Oxford, Oxford, OX1 3QU, United Kingdom
- Graduate Partner Program, Sackler School of Medicine, Tel
Aviv University, Tel Aviv, 69978, Israel
| | - Erell Le Poëc-Celic
- Institut National Des Sciences Appliquées de
Toulouse, Toulouse, 31400, France
| | - Petcharat Leoyklang
- Medical Genetics Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda MD, 20892, USA
| | - Heidi Dorward
- Medical Genetics Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda MD, 20892, USA
| | - Dominic S. Alonzi
- Oxford Glycobiology Institute, Department of Biochemistry,
University of Oxford, Oxford, OX1 3QU, United Kingdom
| | - Nikolay V. Kukushkin
- Oxford Glycobiology Institute, Department of Biochemistry,
University of Oxford, Oxford, OX1 3QU, United Kingdom
| | - Bixue Xu
- UPMC Université Paris 06, Institut Parisien de
Chimie Monléculaire, Paris, 75005, France
| | - Yongmin Zhang
- UPMC Université Paris 06, Institut Parisien de
Chimie Monléculaire, Paris, 75005, France
| | - Matthieu Sollogoub
- UPMC Université Paris 06, Institut Parisien de
Chimie Monléculaire, Paris, 75005, France
| | - Yves Blériot
- UPMC Université Paris 06, Institut Parisien de
Chimie Monléculaire, Paris, 75005, France
- IC2MP, UMR, CNRS 7285, Université de Poitiers,
Poitiers Cedex, 86022, France
| | - William A. Gahl
- Medical Genetics Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda MD, 20892, USA
- Office of Rare Diseases Research, Office of the Director,
National Institutes of Health, Bethesda MD, 20892, USA
| | - Marjan Huizing
- Medical Genetics Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda MD, 20892, USA
- To whom correspondence should be addressed.
. Tel. (++1)
301 4022797. Fax (++1) 301 4807825.
. Tel.
(++44) 1865 275725. Fax. (44) (0) 1865 275216
| | - Terry D. Butters
- Oxford Glycobiology Institute, Department of Biochemistry,
University of Oxford, Oxford, OX1 3QU, United Kingdom
- To whom correspondence should be addressed.
. Tel. (++1)
301 4022797. Fax (++1) 301 4807825.
. Tel.
(++44) 1865 275725. Fax. (44) (0) 1865 275216
| |
Collapse
|
136
|
Yamaji T, Hanada K. Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. PLoS One 2014; 9:e88124. [PMID: 24498430 PMCID: PMC3912166 DOI: 10.1371/journal.pone.0088124] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2013] [Accepted: 01/06/2014] [Indexed: 12/27/2022] Open
Abstract
Sphingolipids are essential components in eukaryotes and have various cellular functions. Recent developments in genome-editing technologies have facilitated gene disruption in various organisms and cell lines. We here show the disruption of various sphingolipid metabolic genes in human cervical carcinoma HeLa cells by using transcription activator-like effector nucleases (TALENs). A TALEN pair targeting the human CERT gene (alternative name COL4A3BP) encoding a ceramide transport protein induced a loss-of-function phenotype in more than 60% of HeLa cells even though the cell line has a pseudo-triploid karyotype. We have isolated several loss-of-function mutant clones for CERT, UGCG (encoding glucosylceramide synthase), and B4GalT5 (encoding the major lactosylceramide synthase), and also a CERT/UGCG double-deficient clone. Characterization of these clones supported previous proposals that CERT primarily contributes to the synthesis of SM but not GlcCer, and that B4GalT5 is the major LacCer synthase. These newly established sphingolipid-deficient HeLa cell mutants together with our previously established stable transfectants provide a ‘sphingolipid-modified HeLa cell panel,’ which will be useful to elucidate the functions of various sphingolipid species against essentially the same genomic background.
Collapse
Affiliation(s)
- Toshiyuki Yamaji
- Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan
- * E-mail: (TY); (KH)
| | - Kentaro Hanada
- Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan
- * E-mail: (TY); (KH)
| |
Collapse
|
137
|
Ishida J, Hinou H, Naruchi K, Nishimura SI. Synthesis of neoglycosphingolipid from methoxyamino-functionalized ceramide. Bioorg Med Chem Lett 2014; 24:1197-200. [DOI: 10.1016/j.bmcl.2013.12.091] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2013] [Revised: 12/19/2013] [Accepted: 12/20/2013] [Indexed: 01/03/2023]
|
138
|
Hudak JE, Bertozzi CR. Glycotherapy: new advances inspire a reemergence of glycans in medicine. CHEMISTRY & BIOLOGY 2014; 21:16-37. [PMID: 24269151 PMCID: PMC4111574 DOI: 10.1016/j.chembiol.2013.09.010] [Citation(s) in RCA: 169] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2013] [Revised: 09/16/2013] [Accepted: 09/30/2013] [Indexed: 12/21/2022]
Abstract
The beginning of the 20(th) century marked the dawn of modern medicine with glycan-based therapies at the forefront. However, glycans quickly became overshadowed as DNA- and protein-focused treatments became readily accessible. The recent development of new tools and techniques to study and produce structurally defined carbohydrates has spurred renewed interest in the therapeutic applications of glycans. This review focuses on advances within the past decade that are bringing glycan-based treatments back to the forefront of medicine and the technologies that are driving these efforts. These include the use of glycans themselves as therapeutic molecules as well as engineering protein and cell surface glycans to suit clinical applications. Glycan therapeutics offer a rich and promising frontier for developments in the academic, biopharmaceutical, and medical fields.
Collapse
Affiliation(s)
- Jason E Hudak
- Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA
| | - Carolyn R Bertozzi
- Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA; Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
| |
Collapse
|
139
|
Li KY, Jiang J, Witte MD, Kallemeijn WW, Donker-Koopman WE, Boot RG, Aerts JMFG, Codée JDC, van der Marel GA, Overkleeft HS. Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors. Org Biomol Chem 2014; 12:7786-91. [DOI: 10.1039/c4ob01611d] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Of six cyclophellitol analogues, the N-pentylaziridine is the most effective retaining human beta-glucosidase inhibitor considering potency and compound stability.
Collapse
Affiliation(s)
- Kah-Yee Li
- Leiden Institute of Chemistry
- Leiden University
- 2300 RA Leiden, the Netherlands
| | - Jianbing Jiang
- Leiden Institute of Chemistry
- Leiden University
- 2300 RA Leiden, the Netherlands
| | - Martin D. Witte
- Stratingh Institute for Chemistry
- University of Groningen
- Groningen, the Netherlands
| | - Wouter W. Kallemeijn
- Department of Medical Biochemistry
- Academic Medical Center
- Amsterdam, the Netherlands
| | | | - Rolf G. Boot
- Department of Medical Biochemistry
- Academic Medical Center
- Amsterdam, the Netherlands
| | - Johannes M. F. G. Aerts
- Leiden Institute of Chemistry
- Leiden University
- 2300 RA Leiden, the Netherlands
- Department of Medical Biochemistry
- Academic Medical Center
| | - Jeroen D. C. Codée
- Leiden Institute of Chemistry
- Leiden University
- 2300 RA Leiden, the Netherlands
| | | | | |
Collapse
|
140
|
Rodríguez-Lavado J, de la Mata M, Jiménez-Blanco JL, García-Moreno MI, Benito JM, Díaz-Quintana A, Sánchez-Alcázar JA, Higaki K, Nanba E, Ohno K, Suzuki Y, Ortiz Mellet C, García Fernández JM. Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier. Org Biomol Chem 2014; 12:2289-301. [DOI: 10.1039/c3ob42530d] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Efficient delivery of pharmacological chaperones for Gaucher disease to macrophages has been achieved.
Collapse
Affiliation(s)
| | - Mario de la Mata
- Centro Andaluz de Biología del Desarrollo (CABD)
- CSIC – Universidad Pablo de Olavide
- 41013 Sevilla, Spain
| | | | | | - Juan M. Benito
- Instituto de Investigaciones Químicas (IIQ)
- CSIC – Universidad de Sevilla
- 41092 Sevilla, Spain
| | - Antonio Díaz-Quintana
- Instituto de Bioquímica Vegetal y Fotosíntesis (IBVF)
- CSIC – Universidad de Sevilla
- 41092 Sevilla, Spain
| | - José A. Sánchez-Alcázar
- Centro Andaluz de Biología del Desarrollo (CABD)
- CSIC – Universidad Pablo de Olavide
- 41013 Sevilla, Spain
| | - Katsumi Higaki
- Division of Functional Genomics
- Research Center for Bioscience and Technology
- Faculty of Medicine
- Tottori University
- Yonago, Japan
| | - Eiji Nanba
- Division of Functional Genomics
- Research Center for Bioscience and Technology
- Faculty of Medicine
- Tottori University
- Yonago, Japan
| | - Kousaku Ohno
- Division of Child Neurology
- Institute of Neurological Sciences
- Faculty of Medicine
- Tottori University
- Yonago, Japan
| | - Yoshiyuki Suzuki
- Tokyo Metropolitan Institute of Medical Science
- Tokyo 156-0057, Japan
| | - Carmen Ortiz Mellet
- Dept. Química Orgánica
- Facultad de Química
- Universidad de Sevilla
- 41012 Sevilla, Spain
| | | |
Collapse
|
141
|
Noble GT, Craven FL, Segarra-Maset MD, Martínez JER, Šardzík R, Flitsch SL, Webb SJ. Sialylation of lactosyl lipids in membrane microdomains byT. cruzi trans-sialidase. Org Biomol Chem 2014; 12:9272-8. [DOI: 10.1039/c4ob01852d] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
SolubleT. cruzi trans-sialidase transformed a synthetic lactosyl glycolipid in microdomains more slowly than the same substrate dispersed across the bilayer surface, producing phospholipid vesicles with a Neu5Ac(α2-3)Gal(β1-4)Glc “glycocalyx”.
Collapse
Affiliation(s)
- Gavin T. Noble
- Manchester Institute of Biotechnology and School of Chemistry
- The University of Manchester
- Manchester, UK
| | - Faye L. Craven
- Manchester Institute of Biotechnology and School of Chemistry
- The University of Manchester
- Manchester, UK
| | | | | | - Robert Šardzík
- Manchester Institute of Biotechnology and School of Chemistry
- The University of Manchester
- Manchester, UK
| | - Sabine L. Flitsch
- Manchester Institute of Biotechnology and School of Chemistry
- The University of Manchester
- Manchester, UK
| | - Simon J. Webb
- Manchester Institute of Biotechnology and School of Chemistry
- The University of Manchester
- Manchester, UK
| |
Collapse
|
142
|
Joosten A, Decroocq C, de Sousa J, Schneider JP, Etamé E, Bodlenner A, Butters TD, Compain P. A Systematic Investigation of Iminosugar Click Clusters as Pharmacological Chaperones for the Treatment of Gaucher Disease. Chembiochem 2013; 15:309-19. [DOI: 10.1002/cbic.201300442] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2013] [Indexed: 01/08/2023]
|
143
|
Stipcevic T, Knight CP, Kippin TE. Stimulation of adult neural stem cells with a novel glycolipid biosurfactant. Acta Neurol Belg 2013; 113:501-6. [PMID: 23846482 DOI: 10.1007/s13760-013-0232-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Accepted: 07/02/2013] [Indexed: 10/26/2022]
Abstract
Glycolipids are amphipathic molecules which are highly expressed on cell membranes in skin and brain where they mediate several key cellular processes. Neural stem cells are defined as undifferentiated, proliferative, multipotential cells with extensive self-renewal and are responsive to brain injury. Di-rhamnolipid: α-L-rhamnopyranosyl-(1-2)α-L-rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoic acid, also referred to as di-rhamnolipid BAC-3, is a glycolipid isolated from the bacteria Pseudomonas aeruginosa. In the previous studies, di-rhamnolipid enhanced dermal tissue healing and regeneration. The present study provides the first assessment of di-rhamnolipid, and glycolipid biosurfactants in general, on the nervous system. Treatment of neural stem cells isolated from the lateral ventricle of adult mice and cultured in defined media containing growth factors at 0.5 and 1 μg/ml of di-rhamnolipid increased the number of neurospheres (2.7- and 2.8-fold, respectively) compared to controls and this effect remained even after passaging in the absence of di-rhamnolipid. In addition, neural stem cells treated with di-rhamnolipid at 50 and 100 μg/ml in defined media supplemented with fetal calf serum and without growth factors exhibited increased cell viability, indicating an interaction between di-rhamnolipid and serum components in the regulation of neural stem cells and neuroprogenitors. Intracerebroventricular administration of di-rhamnolipid at 300 and 120 ng/day increased the number of neurospheres (1.3- and 1.63-fold, respectively) that could be derived from the anterior lateral ventricles of adult mice. These results indicate that di-rhamnolipid stimulates proliferation of neural stem cells and increases their endogenous pools which may have therapeutic potential in managing neurodegenerative or neuropsychiatric disorders and promoting nervous tissue regeneration following injury.
Collapse
|
144
|
Schönemann W, Gallienne E, Ikeda-Obatake K, Asano N, Nakagawa S, Kato A, Adachi I, Górecki M, Frelek J, Martin OR. Glucosylceramide Mimics: Highly Potent GCase Inhibitors and Selective Pharmacological Chaperones for Mutations Associated with Types 1 and 2 Gaucher Disease. ChemMedChem 2013; 8:1805-17. [DOI: 10.1002/cmdc.201300327] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Indexed: 11/11/2022]
|
145
|
Titov DV, Gening ML, Tsvetkov YE, Nifantiev NE. Conjugates of cyclooligosaccharide scaffolds and carbohydrate ligands: Methods for synthesis and the interaction with lectins. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2013; 39:509-46. [DOI: 10.1134/s1068162013050142] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
146
|
Martinková M, Pomikalová K, Gonda J, Vilková M. A common approach to the total synthesis of l-arabino-, l-ribo-C18-phytosphingosines, ent-2-epi-jaspine B and 3-epi-jaspine B from d-mannose. Tetrahedron 2013. [DOI: 10.1016/j.tet.2013.07.028] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
147
|
Kjellberg MA, Mattjus P. Glycolipid transfer protein expression is affected by glycosphingolipid synthesis. PLoS One 2013; 8:e70283. [PMID: 23894633 PMCID: PMC3722133 DOI: 10.1371/journal.pone.0070283] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2013] [Accepted: 06/19/2013] [Indexed: 11/25/2022] Open
Abstract
Members of the glycolipid transfer protein superfamily (GLTP) are found from animals and fungi to plants and red micro-alga. Eukaryotes that encode the glucosylceramide synthase responsible for the synthesis of glucosylceramide, the precursor for most glycosphingolipids, also produce GLTPs. Cells that does not synthesize glucosylceramide neither express GLTPs. Based on this genetic relationship there must be a strong correlation between the synthesis of glucosylceramide and GLTPs. To regulate the levels of glycolipids we have used inhibitors of intracellular trafficking, glycosphingolipid synthesis and degradation, and small interfering RNA to down-regulate the activity of glucosylceramide synthase activity. We found that GLTP expression, both at the mRNA and protein levels, is elevated in cells that accumulate glucosylceramide. Monensin and brefeldin A block intracellular vesicular transport mechanisms. Brefeldin A treatment leads to accumulation of newly synthesized glucosylceramide, galactosylceramide and lactosylceramide in a fused endoplasmic reticulum-Golgi complex. On the other hand, inhibiting glycosphingolipid degradation with conduritol-B-epoxide, that generates glucosylceramide accumulation in the lysosomes, did not affect the levels of GLTP. However, glycosphingolipid synthesis inhibitors like PDMP, NB-DNJ and myriocin, all decreased glucosylceramide and GLTP below normal levels. We also found that an 80% loss of glucosylceramide due to glucosylceramide synthase knockdown resulted in a significant reduction in the expression of GLTP. We show here that interfering with membrane trafficking events and simple neutral glycosphingolipid synthesis will affect the expression of GLTP. We postulate that a change in the glucosylceramide balance causes a response in the GLTP expression, and put forward that GLTP might play a role in lipid directing and sensing of glucosylceramide at the ER-Golgi interface.
Collapse
Affiliation(s)
- Matti A Kjellberg
- Biochemistry, Department of Biosciences, Åbo Akademi University, Turku, Finland
| | | |
Collapse
|
148
|
Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis 2013; 12:98. [PMID: 23835113 PMCID: PMC3716967 DOI: 10.1186/1476-511x-12-98] [Citation(s) in RCA: 129] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2013] [Accepted: 06/28/2013] [Indexed: 02/06/2023] Open
Abstract
Diabetes mellitus is a metabolic disease with multiple complications that causes serious diseases over the years. The condition leads to severe economic consequences and is reaching pandemic level globally. Much research is being carried out to address this disease and its underlying molecular mechanism. This review focuses on the diverse role and mechanism of ceramide, a prime sphingolipid signaling molecule, in the pathogenesis of type 1 and type 2 diabetes and its complications. Studies using cultured cells, animal models, and human subjects demonstrate that ceramide is a key player in the induction of β-cell apoptosis, insulin resistance, and reduction of insulin gene expression. Ceramide induces β-cell apoptosis by multiple mechanisms namely; activation of extrinsic apoptotic pathway, increasing cytochrome c release, free radical generation, induction of endoplasmic reticulum stress and inhibition of Akt. Ceramide also modulates many of the insulin signaling intermediates such as insulin receptor substrate, Akt, Glut-4, and it causes insulin resistance. Ceramide reduces the synthesis of insulin hormone by attenuation of insulin gene expression. Better understanding of this area will increase our understanding of the contribution of ceramide to the pathogenesis of diabetes, and further help in identifying potential therapeutic targets for the management of diabetes mellitus and its complications.
Collapse
|
149
|
López Marín L, Gutiérrez-Solana LG. Tratamiento de las enfermedades lisosomales en la población pediátrica. ACTA ACUST UNITED AC 2013. [DOI: 10.1016/s1696-2818(13)70132-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
150
|
Alfonso P, Andreu V, Pino-Angeles A, Moya-García AA, García-Moreno MI, Rodríguez-Rey JC, Sánchez-Jiménez F, Pocoví M, Ortiz Mellet C, García Fernández JM, Giraldo P. Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease. Chembiochem 2013; 14:943-9. [PMID: 23606264 DOI: 10.1002/cbic.201200708] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2012] [Indexed: 12/12/2022]
Abstract
New human β-glucocerebrosidase (GCase) ligands with rigid 1,6-anhydro-β-L-idonojirimycin cores have been designed with the aid of molecular modeling. Efficient pharmacological chaperones for the L444P (trafficking-incompetent) mutant GCase enzyme associated with type 2 and 3 Gaucher disease (GD) were identified.
Collapse
Affiliation(s)
- Pilar Alfonso
- Biomedical Network Research Center on Rare Diseases (CIBERER), ISCIII, Alvaro de Bazán 10 bajo, 46010 Valencia, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|